Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

3 No-Brainer Biotech Stocks to Buy in November

TheMotleyFool

0 0

3 No-Brainer Biotech Stocks to Buy in NovemberPhoto, wide shot, wide-angle lens, Pharmaceutical company, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ae4a134-dd01-4c80-a621-18399f5a2541.png

Some investing decisions are really hard to make. Others, though, can be quick and easy. That's the case when the stocks offer compelling growth prospects that are undeniable.

We asked three Motley Fool contributors to pick no-brainer biotech stocks to buy in November. Here's why they chose Bristol Myers Squibb (NYSE: BMY), Exelixis (NASDAQ: EXEL), and Vertex Pharmaceuticals (NASDAQ: VRTX).

Image source: Getty Images.

Source Fool.com

Like: 0

VRTX

Teilen